CUMBERLAND PHARMACEUTICALS INC 8-K

Accession 0001628280-18-000933

Filing information

CIK: 0001087294
Report date: 2018-02-02
Filing date: 2018-02-02
Form: 8-K
Primary document: a8k-amifostinestudy.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.